Top Tweets for #ImmuneCheckpointBlockade
Our latest published phase 1 article in @NatureMedicine | Linavonkibart & pembrolizumab in #immunecheckpointblockade -resistant #solidtumors | Enjoyed being part of this effort & this group of PIs #DrugDevelopment #Immunooncology
@MoffittNews
https://t.co/purKgq6yRg
Our latest published phase 1 article in @NatureMedicine | Linavonkibart & pembrolizumab in #immunecheckpointblockade -resistant solid tumors | Enjoyed part of this effort & this group of PIs #DrugDevelopment #Immunooncology @MoffittNews
https://t.co/vi0gH4pR6A
📢 Special Research Seminar
Join us for a @OhioStateMedOnc @OhioStatePIIO faculty candidate talk featuring Dr. No Joon Song!
🧬 "#Tumor-associated #NKcells mediate resistance to #ImmuneCheckpointBlockade therapy"
📅 Tuesday, Sept 9, 2025
🕙 10–11 AM
📍 115 BRT
Online!🍹
Integrated multi-omics profiling reveals the role of the #DNAmethylation landscape in shaping biological heterogeneity and clinical behaviour of #metastaticmelanoma
Look here💡
https://t.co/q8hLcnidmo
#ImmuneCheckpointBlockade
#DNMTinhibitor
Recently published:
Spatial context of #immunecheckpoints as predictors of overall survival in patients with resectable #colorectalcancer independent of standard TNM stages, by Hao Kong et al.
https://t.co/XIyb00LUAW
@jiangh7 #ImmuneCheckpointBlockade #openaccess
$CRVS Expecting further revaluation based on pipeline towards $20 ($1B-$1.5B):
#ITK inhibition #soquelitinib
Ph1 - Atopic dermatitis
Ph2 - Solid tumor, #RCC, w/ relapsed #immunecheckpointblockade patients!
Ph 3 - #PTCL
#A2AR #Ciforadenant
Ph2 - Combo RCC w/ anti-PD-1 anti-CTLA-4
Our latest POSTER with @NatRevImmunol explores rationale combinations of #immunecheckpointblockade of #PD1-#PDL1, with other therapies aimed at targeting effector T cells, innate immune + regulatory T cells, the #TME & cancer cells.
Check it out now!
https://t.co/MegTrzAAHa
A carrier-free photodynamic bioregulator (CASN) was developed to complement #ImmuneCheckpointBlockade therapy and improve immunotherapeutic efficacy against #TripleNegativeBreastCancer by reprogramming the lactic acid #TumorMicroenvironment.
Read: https://t.co/IgEOFuFduV
How does #melanoma resist #ImmuneCheckpointBlockade?
Researchers at @vib_ccb explored the role of TCF4 and cells in a #mesenchymal-like state.
@jchrismarine @pozniak_joanna @DennisPedri
📃 @CellCellPress: https://t.co/7Kue0NO0dp
▶️: https://t.co/Pog4YP16bg
Happy to share our thoughts on what the future holds for oncolytic virotherapy. More data forthcoming in conjunction with #immunecheckpointblockade
@MarkTysonMD @cgoncology
https://t.co/c3BuiBdbK3
.@MSKLibrary feature: Novel Genetic Subtypes of Urothelial Carcinoma w/Differential Outcomes on #ImmuneCheckpointBlockade
@MichalSarfaty @MSK_DeptOfMed @MSKPathology @AMRegazzi @MSKBiostats @illumina @bengrbm @DrRosenbergMSK @GeneCollector @JCO_ASCO
https://t.co/UPRWwClUcN
How do bacteria affect #ImmuneCheckpointBlockade? 🦠
Researchers at @GustaveRoussy investigated if bacteria that rebound after antibiotics are administered affect cancer treatment responses.
@ScienceMagazine paper: https://t.co/6b9cbLo9g7
Discussion: https://t.co/lWhXfOn9Xf
Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune checkpoint blockade and minimizes the associated side effects. #cancer #cancertreatment #immunecheckpointblockade #tohokuuniversity
https://t.co/u0CrskFC20
@NCICancerBio A3: Using #machinelearning (#ML), Andrew Patterson and @AuslanderNoam @TheWistar determined genomic predictors of response to #immunecheckpointblockade in #melanoma. Read more @NatureComms: https://t.co/OPQ7de3v75 #MAMChat23 #MelanomaAwarenessMonth
IL7 genetic variation and toxicity to #ImmuneCheckpointBlockade in patients with #Melanoma https://t.co/RMPBJLfPIM
Awesome job by PhD candidate @amirmoyo, who represented #MIIProud, #PIIO @Hazemghoneim11 Lab at #AAI2023 with poster titled "Targeting #epigenetic crosstalk that restrains the responses of #ExhaustedTcells to #ImmuneCheckpointBlockade therapy"!!
Our data on #spatial predictors of neoadjuvant #immunecheckpointblockade has just been presented at @AACR's annual meeting. It was such an experience to be part of a session w. other panelists sharing their discoveries on tumor biology using spatial biology in Orlando #AACR23
Coming to #AACR23? Come see me on Tuesday 18th if you want to hear about how we spatially modeled the tumor microenvironment to understand clinical response to neoadjuvant immunotherapy in urothelial and head and neck cancer
Autoantibodies reactive to cardiac antigens after concurrent #radiotherapy and #ImmuneCheckpointBlockade are ID’d. Data highlight #Bcells as potential targets to mitigate #cardiotoxicity, in this study by Yan, Hooper, Chen, Lu et al.
https://t.co/6cERv9cbJb
#CancerImmunology
She is showing collaborative work with @MathCancer. They found that immune aggregates from #immunecheckpointblockade limit immune cell trafficking into tumors via computational modeling. #AACR23
Poster 707—
Find out mechanisms behind resistance to #ImmuneCheckpointBlockade and how these can be overcome with therapy—
https://t.co/7ieDdViwMs
#CIRReviewerStar #CancerImmunology #AACR23
Most Popular Users
Elon Musk 
@elonmusk
240.5M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.3M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.6M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.8M followers
KATY PERRY
@katyperry
87.5M followers
Taylor Swift
@taylorswift13
81.3M followers
Lady Gaga
@ladygaga
72.9M followers
Kim Kardashian
@kimkardashian
69.7M followers
Virat Kohli
@imvkohli
69.6M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.8M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
62.3M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.6M followers